| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $502.1M | +126.3% |
| Cost of Revenue | $21.0M | +440.5% |
| R&D Expense | $452.0M | -10.8% |
| SG&A Expense | $531.2M | +83.9% |
| Operating Income | -$523.4M | +11.7% |
| Pre-tax Income | -$732.5M | -35.1% |
| Income Tax | $435K | -62.3% |
| Net Income | -$732.9M | -34.9% |
| EPS (Basic) | -$3.78 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $570.1M | -16.3% |
| Accounts Receivable | $139.4M | +2853.1% |
| Inventory | $26.8M | — |
| Current Assets | $797.7M | +10.7% |
| Total Assets | $936.0M | +1.8% |
| Current Liabilities | $288.0M | +86.5% |
| Long-term Debt | $2.01B | +359.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$445.9M | +14.4% |
| Capital Expenditures | $1.1M | +17.6% |
| Investing Cash Flow | -$24.5M | -140.3% |
| Financing Cash Flow | $359.3M | -52.0% |
| Free Cash Flow | -$447.0M | +14.3% |
| -31.3% |
| EPS (Diluted) | -$3.78 | -31.3% |
| Total Liabilities |
| $3.01B |
| +26.7% |
| Stockholders' Equity | -$2.09B | -42.1% |